^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    bafisontamab (EMB-01)

    i
    Other names: EMB-01, FIT-013a, EMB01, FIT013a, EMB 01, FIT 013a
    Associations
    News

    Trials

    Company:
    EpimAb Biotherap
    Drug class:
    EGFR inhibitor, c-MET inhibitor
    Related drugs:
    Associations
    News

    Trials

    Apply
    EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers (NCT05176665)
    Phase 1/2
    Shanghai EpimAb Biotherapeutics Co., Ltd.
    Recruiting
    Last update posted :
    09/29/2023
    Initiation :
    10/21/2021
    Primary completion :
    08/04/2024
    Completion :
    08/31/2024
    EGFR • KRAS • BRAF • ALK • NRAS • ROS1 • FGFR • NTRK
    |
    KRAS mutation • BRAF mutation • NRAS mutation • MET amplification • EGFR amplification • EGFR overexpression
    |
    bafisontamab (EMB-01)
    A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors (NCT03797391)
    Phase 1/2
    Shanghai EpimAb Biotherapeutics Co., Ltd.
    Recruiting
    Last update posted :
    05/31/2023
    Initiation :
    12/13/2018
    Primary completion :
    03/14/2025
    Completion :
    01/15/2026
    EGFR
    |
    EGFR mutation • EGFR T790M
    |
    bafisontamab (EMB-01)